64857-08-5Relevant articles and documents
Design and optimization of novel hydroxamate-based histone deacetylase inhibitors of bis-substituted aromatic amides bearing potent activities against tumor growth and metastasis
Yang, Feifei,Zhang, Tao,Wu, Haigang,Yang, Yang,Liu, Ning,Chen, Ang,Li, Qiang,Li, Jingjie,Qin, Liwen,Jiang, Beier,Wang, Xin,Pang, Xiufeng,Yi, Zhengfang,Liu, Mingyao,Chen, Yihua
, p. 9357 - 9369 (2015/01/09)
Histone deacetylases (HDACs) are one of the most promising drug targets for cancer therapy, and since more than 90% of all cancer-related deaths are associated with tumor metastasis, developing strategies to inhibit tumor metastasis while retaining anti-t
